Opportunity ID: 321482

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-20-029
Funding Opportunity Title: Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 10, 2019
Last Updated Date: Oct 10, 2019
Original Closing Date for Applications: Jan 07, 2022
Current Closing Date for Applications: Jan 07, 2022
Archive Date: Feb 12, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Native American tribal governments (Federally recognized)
Small businesses
State governments
Private institutions of higher education
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention. Applications may propose treatment or prevention products delivered using sustained release platforms (oral, injection, implant or direct delivery to HIV target mucosa) that will provide a minimum of 1 week for oral (treatment) or a minimum of once a month for all other drug delivery systems for prevention and treatment.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-20-029.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00259206 Dec 06, 2019 Jan 24, 2022 View
FORMS-E Use for due dates on or before May 24, 2020 PKG00255768 Dec 06, 2019 May 24, 2020 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269726 Oct 28, 2021 Jan 07, 2022 View

Package 1

Mandatory forms

321482 RR_SF424_2_0-2.0.pdf

321482 PHS398_CoverPageSupplement_5_0-5.0.pdf

321482 RR_OtherProjectInfo_1_4-1.4.pdf

321482 PerformanceSite_2_0-2.0.pdf

321482 RR_KeyPersonExpanded_2_0-2.0.pdf

321482 PHS398_ResearchPlan_4_0-4.0.pdf

321482 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

321482 RR_Budget_1_4-1.4.pdf

321482 RR_SubawardBudget30_1_4-1.4.pdf

321482 PHS398_ModularBudget_1_2-1.2.pdf

321482 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

321482 RR_SF424_2_0-2.0.pdf

321482 PHS398_CoverPageSupplement_4_0-4.0.pdf

321482 RR_OtherProjectInfo_1_4-1.4.pdf

321482 PerformanceSite_2_0-2.0.pdf

321482 RR_KeyPersonExpanded_2_0-2.0.pdf

321482 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

321482 RR_Budget_1_4-1.4.pdf

321482 RR_SubawardBudget30_1_4-1.4.pdf

321482 PHS398_ModularBudget_1_2-1.2.pdf

321482 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 3

Mandatory forms

321482 RR_SF424_5_0-5.0.pdf

321482 PHS398_CoverPageSupplement_5_0-5.0.pdf

321482 RR_OtherProjectInfo_1_4-1.4.pdf

321482 PerformanceSite_4_0-4.0.pdf

321482 RR_KeyPersonExpanded_4_0-4.0.pdf

321482 PHS398_ResearchPlan_4_0-4.0.pdf

321482 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

321482 RR_Budget_3_0-3.0.pdf

321482 RR_SubawardBudget30_3_0-3.0.pdf

321482 PHS398_ModularBudget_1_2-1.2.pdf

321482 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T09:46:56-05:00

Share This Post, Choose Your Platform!

About the Author: